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Table 1 Effect of nucIeoside-IgG2a conjugate on appearance of anti-nucIeoside antibody forming cells 
Treatment 10 d 
before immunisation 
Direct (AGCT) PFC per spleen 
on day 7 p 
Indirect (AGCT) PFC per spleen 
on day 7 p 
None 
AGCT-IgG2a 




Seven BALB(c mice were treated with 0.2 mg of AGCT-IgG2a, given i.v. and, together with seven untreated mice, were immunised i.p. 
with 0.2 m~ of AGCT-KLH in complete Freund's adjuvant 10 d later. Direct and indirect PFC were measured on day 7, as described in the 
legend to Fig. 1. Values are means ± s.e. 
Table 2 NucIeoside specificity of tolerance 
Treatment 10 d 
before immunisation 














8,848 ± 3,538 
883± 710 <0.01 
Seven BALB(c mice were treated with 0.2 mg of G-IgG2a and, together with seven untreated mice, were immunised i.p. with 0.2 mg of 
AG<;T-KLH in complete Freund:s adjuvant.l.0d later. Individual nucIe,!side-S~BC target cells were prepared as in the legend to Fig. I, 
but In each case 10 mg of nucIeoslde were oXldlsed In 1.0 ml of O.IM sodlUm penodate. Dlrect PFC were measured 6 d after immunisation. 
Values are means±s.e. 
immunised with all four nucleosides on the immunogenic 
carrier, there was some variation in the number of PFC 
specific for each nucleoside. This reflected at the cellular 
level of the immunodominance of guanosine and the low 
immunogenicity of adenosine that we have noted previously 
for serum antibody responses'. Finally, from a technical 
point of view, the modifications of the technique c 
Erlanger and Beiser' to link nucleosides to sheep cells 
should be noted. The ionic strength had to be maintained 
to prevent lysis. The use of 0.15 M bicarbonate did this and 
provided a suitable pR for the Schiff base formation. The 
use of t-butylamine borane complex in place of sodium 
borohydride was important in preventing damage to the 
erythrocytes during reduction of the Schiff base, and the 
reduction time was brief. 
The immune response to nucleic acid antigens is 
important from at least two points of view. First, since 
anti-nucleic acid antibodies are involved in autoimmune 
disease', the suppression of tbis response can be of 
therapeutic importance; and second, strain differences in 
the ability of mice to respond to nucleic acid antigens have 
been observed9 and might offer the opportunity to study the 
genetic basis of both immunity and tolerance to defined 
determinants of naturally occurring antigens. The develop-
ment of an assay that permits the detection of antibody 
forming cells to either all four nucleosides simultaneously 
or to individual nucleosides is useful for the study of these 
phenomena. 
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T -cell cytotoxicity in the absence 
of viral protein synthesis in target cells 
CYTOTOXIC T cells lyse only those virus infected target cells 
in vitra which express, in addition to the viral antigenes), 
those K or D region products of the major histocompati-
bility complex (MHC) which were present during anti-viral 
sensitisation in viva. This 'associative recogniton' by cyto-
toxie T cells could reflect the interaction of two T-cell 
receptors with specificity for target K or D gene products 
and independently for the viral antigen, or one receptor 
P ____ 
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Fig. 1 Separation of Sendai virus envelope pro tein on SDS-
polyacrylamide gels. Sendai virus (8 mg mi-I) in phosphate-
buffered saline without Mg or Ca (PBS-A), 1.5 x 105 haemag-
glutinating units (HAU) per ml were treated with 0.25% NP 40 
for 15 min at 20°C (ref. 6). The suspension was centrifuged 
at 120,OOOg for 1 hat 4 °C to remove partially disrupted virions' 
and nucJeocapsids. The supernatant was dialysed for 4 d at 4 °C 
against twice daily changes of PBS-A using spectrophor 2 
tubing (Raven Scientific). The reassembled membrane particles 
were concentrated by centrifugation at 120,OOOg for 1 h at 
4 °C and the pellet was resuspended in PBS-A. Envelopes were 
active in assays for haemagglutination', neuraminidase8 and 
haemolytic activities·. Envelopes were analysed by SDS-poly-
acrylamide electrophoresis by the method of Laemmli10 using 
10% gels. P, polymerase; HNA, haemagglutinin; NA, Neura-
minidase; F b fusion factor; M, M-protein. 
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with specificity for virally alte red K or D region products 
(see ref. land refs therein). There are various ways that 
the MHC antigens could be altered, including 'modification 
from within', where the virus modifies host protein synthesis 
by interfering with transcription', translation or post-
translation al glycosylation; or 'modification from without' 
where enzymic or chemical alteration of cell membrane 
proteins are induced by virus activity at the cell surface. 
In this re port we show that inactivated Sendai virus or 
isolated Sendai virus envelopes can serve to modify a cell 
and make it a specific target for Sendai-immune T-cell 
killing, thus excJuding the possibility of 'modification from 
within' in this system. 
Sendai virus-prim cd BALB/c spleen cells, boosted in vitro 
with syngeneic inrected blast cells, specifically killed Sendai 
virus-infected syngeneic target cens; primed spleen cells 
boosted with syngeneic non-infected cells did not (Table 1). 
Killer cells after secondary stimulation were T cells as shown 
by treatment with anti-Ly-sera (U. K. and P . Beverley, un-
published). Three approaches were used to show that syn-
thesis of viral protein is not required in the target cell in 
order for it to be killed by vi rally sensitised T cells. First, 
cells incubated with ultraviolet-irradiated Sendai virus were 
lysed hy sensitised T celJs (data not shown). Second, cells 
exposed to purified Sendai virus, inactivated with ß-propio-
lactone- which abolishes induction of protein synthesis by 
inactivated particles'-also proved to be effective target cells 
(Table 1). Treatment with ß-propiolactone reduced the 
number of plaque forming units by 10'. Since the ratio of 
particles to plaque forming units would be expected to be no 
better than 10: 1 (J. Skchel, personal communication) and 
target-to-partic1e ratio was I : 106 , it follows that, at most, 
one in a thousand celJs were infected with a live virus. 
Sendai virus specific killer celJs generated by secondary 
stimulation in vitra lyse only H-.?-compatible infected target 
cells (U. K., unpublished) and the same restriction is seen 
using target celJs incu ba ted with inactivated Sendai virus 
(Table 2). Third, cells exposed to isolated envelopes from 
Sendai virus, which contained mainly the two surface glyco-
proteins with a very smalJ amount of nucleocapsid and 
almost no detectable M-protein (Fig. 1), were susceptible 
to T cell-mediated lysis. To exclude nonspecific effects of 
thc Sendai envelopes on target cells, influenza virus-specific 
cytotoxic T cells were tested on these target cells, and 
found to be ineffective (Table 3). 
In several virus infections, target celJ formation requires 





o 10 100 
flg virus protein per 106 target cells 
Fig.2 T cell-mediated lysis of P-815 target cells exposed to dilu-
tions of purified Sendai virus inactivated with ß-propiolactone 
(B-PL). Sendai virus was grown in the allantoic cavity of 
IO-d-old embryonated fowl eggs and purified by centrifugation 
through a sucrose gradient (20-55 % in PBS-A). The virus-
containing band was collected and concentrated by centri-
fugation at 120,OOOg for 1 h. Inactivation was achieved by 
incubating the purified virus (2 mg per ml, 4 x 10' HAU per ml, 
1 Ilgi:::: 10" virus particles) for 18 h at 4 °C with ß-propiolactone 
(Sigma) at a concentration of 0.025 %. ß-propiolactone was 
inactivated by incubation for 30 min at 37 oe. Inactivation was 
tested by egg infectivity titration". 0 - 0 , Lysis of P-815 
cells exposed 2 h befoTe test with dilutions of B-PL-Sendai 
virus (100 Ilg virus per 106 cells, about 105 particles per cell). 
0, P-8l5 targets infected overnight with 20 PFU per cell (1 PFU 
<; 10 particles). V, Non-infected P-815 control cells. Assay 
conditions identical to Table I, incubation time 3 h, ratio of 
killer-target cells, 5: 1. 
expression of viral pro teins on the cell surface. The ability 
of Sendai virus to by-pass these processes may be due to 
its unique capacity to mediate ceIl-ceIl fusion, which could 
allow the insertion of large amounts of virus glycoprotein 
into the target cell membrane. From the dose-response 
curve (Fig. 2) of target cell formation with dilutions of 
ß-propiolactone inactivated Send ai virus, it can be seen that 
about 106 particles per target cell were required to induce 
Table 1 Lysis of syngeneic target cells incubated with infective and inactivated Sendai virus or vesicles containing viral envelope proteins 
Targets 
Responder Stimulator Culture Ratio 
cells cells day K:T P-815 P-815/Sendai P-815/B-PL-S P-815/Sendai env. 
BALB/c, BALB/c con A treated blasts, 5 10:1 1.1 43.5 42.0 18.1 
Sendai immune Sendai infected 5:1 0.3 26.6 26.3 9.7 
2.5:1 1.7 13.9 15.1 6.3 
BALB/c, BALB/c con A treated blasts 5 10:1 2.8 0.5 1.3 0.4 
Sendai immune 5:1 3.5 0.9 0.9 1.0 
BALB/c, BALB/c con A treated blasts, 5 10:1 0.1 0.9 4.0 1.6 
Normal Sendai infected 5:1 0.6 0.4 3.6 0.5 
BALB/c mice were immunised to Sendai virus by i.p. injection of 0.2 ml allantoic fluid containing 10
' 
plaque forming units (PFU) of virus'. 
Six weeks later spleens were collected and incubated in RPMI medium containing 10% foetal calf serum, glutamine and 5 x 10-5 M 
2-mercaptoethanol in 2 ml weil Iinbro plates in presence of stimulated cells. Stimulator cells were prepared by incubation of spleen cells in 
culture medium containing 2.5 Ilg ml - 1 concanavalin A (con A) for 48 h followed by overnight infection with 20 PFU per cell Sendai virus and 
2,000 rad irradiation. 5 x 10" responder cells were incubated with 5 x 10" stimulator cells. Cytotoxic T cells were collected from cultures 4-7 d 
later4 and a "Cr release assay was performed with 5 x 103 syngeneic tumour target cells per weIl'. Target cells were a, 51Cr labelIed non-infected 
P-815 cells; b, P-815 cells infected overnight with 20 PFU per cell Sendai virus; c, P-815 cells pre-incubated for 2 h with ß-propiolactone (B-PL) 
inactivated (see legend Fig. 2), purified Send ai virus in a protern concentration of 50 Ilg per 106 target cells; d, P-815 cells pre-incubated for 2 h 
with Sendai envelope (env.) proteins (see legend to Fig. 1) in a pro tein concentration of 50 Ilg per 106 target cells. Results are from triplicate 
assays; S.E.M. were always less than 3. Spontaneous lysis, wh ich did not exceed 15-20%, is subtracted. 
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Table 2 Lysis of target cells treated with ß-propiolactone inactivated Sendai virus is H-2 restricted 
Responder Stimulator P-815 S-B-PL L-929 S-B-PL EL-4 S-B-PL 
cells cells (H-2"d) (H-2'k) (H_2bb) 
BALB/c normal 
(H_2dd) 
BALB/c con A treated blast, Sendai infected 3.1 1.4 2.5 
BALB/c immune 
(H_2dd) 
BALB/c con A treated blasts, Sendai infected 46.1 1.5 11.9 
CBAimmune CBA con A treated blasts, Sendai infected 2.4 30.6 3.0 (H-2··) 
C57BL6 immune 
(H_2bb) 
C57 BL6 con A treated blast, Sendai infected 3.8 32.5 
Conditions of immunisation and in vitra restimulation were as for Table 1. Cells were collected and tested on culture day 6. Target cells 
were incubated with B-PL-virus, in a protein concentration of 50 Ilg per 10" target cells. Results are from triplicate assays, ratio of killer-target 
cells is 20:1, incubation time 4 h. 
a comparable degree of kilIing as seen with infected target 
cells. Since the percentage of particles which actually fuse 
with the target cells is unknown, the number of fused 
particles per cell necessary for target cell formation cannot 
be estimated. Failure to use sufficiently high concentrations 
of virus during target cell incubation may explain previous 
negative findings (ref. 12, and U.K., unpublished). 
ß-propiolactone-Sendai virus-treated target cells were 
Iysed to a similar extent as target cells incubated with live 
virus, but target cells which were produced with Sendai 
virus envelope vesicles were consistently Iysed at a Iower 
plateau level. Two explanations are possible. There could 
be two populations of Sendai virus specific cytotoxic T cells 
within'. lf there are alterations of H-2 gene products these 
must occur from without, at the cell surface. Envelopes 
contain neuraminidase activity, but cleavage of neuraminic 
acid seems not to change the H-2 surface antigen speci-
ficityI6.17. We do not know if there are other residual 
enzyme activities such as proteases or glycosidases remain-
ing in the envelopes. It is also possible that cross-Iinking 
of sialic acids by the viral haemagglutinin might change 
the surface distribution of H-2, and sometimes create 
effective target antigens. 
Which then are the viral antigens on ceIl surfaces recog-
nised by the T cells? Recent studies on influenza virus-
specific CTL have suggested that the M-protein which is 
Table 3 Virus-specific lysis of target cells incubated with inactivated Sendai virus or Sendai virus envelopes 
Responder Stimulator Culture 
Targets 
Ratio 
cells celIs day K:T P-815 P-815/influenza P815/Sendai P-815/B-PL-S P-815/Sendai env. 
BALB/c, P-815, Sendai infected 5 10:1 4.3 2.3 39.6 28.1 19.3 
Sendai immune 5:1 -2.5 3.0 37.8 19.8 14.2 
BALB/c, P-815, influenza infected 5 10:1 -0.9 27.4 0.8 1.3 1.8 
influenza immune 5:1 0.2 13.9 0.3 -3.8 3.9 
(C3H x DBA/2) F" BALB/c LPS blasts, 5 10:1 -0.29 3.7 26.5 27.2 
Sendai immune Sendai infected 5:1 1.02 1.4 8.6 8.5 
(C3H xDBA/2) F" BALB/c LPS blasts, 5 10:1 0.3 19.8 3.4 3.8 
influenza immune influenza infected 5:1 2.9 11.3 0.5 2.9 
Responder cells (BALB/c, (C3H x DBA/2) F I) were collected from mice injected Lp. 6 weeks previously with 107 PFU Sendai virus or influenza 
virus. The influenza strain A/Jap/Bel/305157 (H 2N I ) a recombinant of A/Jap/305/57 (H 2N 2) and A/Bel/42 (HoN,) (kindly supplied by 
Dr J. Skehel) was used. Conditions of in viva sensitisation and in vitra boosting of cells were similar to those used for secondary cytotoxic T-
cell generation against Sendai virus. Stimulator cells were BALB/c lymphocyte blasts after 48 h incubation in 50 Ilg ml-' lipopolysaccharide 
containing medium or P-815 tumour cells. Stimulator cells were infected overnight with 20 PFU per cell and irradiated with 2,000 rad (bi asts) 
or 8,000 rad (P-815). Ratio of stimulator to responder cells and "Cr release assay conditions were identical to those described in the legend to 
Table I. 
with receptors for different viral antigens; however, antigens 
on envelope-treated target cells are at least partially shared 
with those of infected target cells since the latter compete 
in cold cell inhibition tests with the lysis of target cells 
exposed to Sendai virus envelopes (da ta not shown). The 
second possibility is that the envelope vesicles are less active 
in fusing with the target cell membrane; this is the more 
likely explanation since the ß-propiolactone inactivated 
virus was active in cell-cell fusion, while the envelopes 
were not. 
These results rule out, at least for Sendai virus infection, 
formation of an 'altered self' by a 'modification from 
not glycosylated and not expressed on cell membranes may 
contribute to target specificitylK. This is very unlikely for 
Sendai virus since the envelope preparations contain only 
two glycoproteins, one with neuraminidase and haemag-
glutinin activity and the other with fusion activity. 
These results show for the first time that target cells for 
virus-specific T -ce 11 lysis can be prepared with vesicles 
containing essentially only viral surface glycoproteins and 
that viral protein synthesis is not required for target cell 
formation. 
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Cellular inactivation by ultrasound 
THE lethai dfect of ultrasound (US) on mammalian cells 
has received relatively little attention. Understandably, 
potential genetic aspects of US have been of prime concern 
to physicians who use US as a diagnostic tool; at the 
average power densities involved (4: 1 W cm- ') little, if any 
cell killing is to be expected. There have been sporadic 
attempts to use higher intensities (~I W cm-') as a treat-
ment modality in cancer therapy',2, but those experiments 
seem to have been based on inadequate cellular studies. 
The etfects of US usually were evaluated in terms of 
morphological criteria rather than on quantitative deter-
mination of the loss of viability as measured by colony 
formation. There are few reports of the effects of US on 
survival of mammalian cells3 ,', and none specifically 
examine hyperthermic interaction . With the increased 
interest in hyperthermia for tumour therapy, attention has 
been directed towards the use of ultrasound to achieve 
tumour heating. In preliminary experiments in which US 
was used to heat the EMT6 sarcoma and KHJJ carcinoma 
in mice, we found a high percentage of tumour cures with 
short (-30 min) treatments at temperatures (43--44 °C) 
where in vitro results of hyperthermia-induced cell kiHing' -7 
would not have ted to aprediction of any cures. We 
thereforc initiated an investigation of the effects of US on 
survival of Chinese hamster cells to see if direct cell 
killing by US could explain our in vivo results, or, as in 
the case of radiofrequency (RF) electromagnetic heating, 
we would be forced to invoke host responses. In particular, 
we examined the thermal and non-thermal components of 
cellular inactivation by USo We report here that there is 
a definite non-thermal cytotoxic etfect of USo Hs relative 
contribution to cell killing is a highly nonlinear function 
of the temperature of the cellular milieu. The survival 
curves show c1early that , beyond an initial threshold, small 
changes in temperature and / or US intensity can give rise 
to impressive changes in survival values. The threshold 
nature of the data strongly suggests that by means of 
overlapping heams, ultrasound energy could be delivered 
to tumour tissue to achieve massive cell killings while 
163 
sparing normal tissue outside the tumour volume to a 
degree far exceeding that of conventional techniques. 
Chinese hamster cells (HA-I) of ovarian origin were 
maintained in Eagle's MEM supplemented with 15 % 
foetal calf serum, penicillin, and streptomycin. The 
cultures were kept in a humidified incubator with a mixture 
of 95 % air and 5% C02, and were routinely checked for 
mycoplasma. To maximise the transmission of the acoustic 
energy and hence minimise heat induced by absorption of 
US, cells were grown as monolayers in specially designed 
stainless steel dishes with Mylar bottoms (130 jlm thick). 
Approximately 8 X 10' cells were seeded within a confined 
area (1.6 cm in diameter) on the thin Mylar film; experi-
ments were always performed on the third day after 
plating when the ce 11 density reached approximately 
5 X 10' cells cm -2 and the cells were still in exponential 
growth. Plating efficiencies of cells trypsinised from the 
Mylar film were 70-90 ':{.. Some experiments were performed 
with cells in suspension; as far as possible, the geometry 
was identical to that used for attached cells. The cloning 
technique of Puck and Marcus was used to determine the 
fraction of viable cells, The US irradiating system con-
sisted of a laboratory-developed signal generator and 
power amplifier driving a piezo-electric transducer (Mettier 
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Fig. 1 Plating efficiencies (normalised to untreated controls) 
against US intensity. Cells were irradiated for 30 min at a, 37 oe; 
b,43 oe. Error bars in this and the succeeding figures show s.e.m. 
Plating efficiency is defined as (no, colonies per dish/no, cells 
plated per dish) x 100. Cells plated per dish represents count-
able cells obtained by enzymic removal from Mylar after 
treatment, 
